Free Trial

ANI Pharmaceuticals (ANIP) SEC Filings & 10K Form

$60.51
-0.25 (-0.41%)
(As of 09/6/2024 ET)

Recent ANI Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/14/2024
7:29 AM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:21 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
8:51 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:26 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:53 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:57 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
4:27 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:30 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:12 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:07 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:41 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:37 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:57 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:38 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:58 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:56 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:11 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:46 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
3:37 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:23 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:51 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:21 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
6:34 AM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:59 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
5:08 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:35 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
6:54 PM
ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:58 PM
ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:59 PM
ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
7:02 PM
ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
7:03 PM
ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:45 PM
ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:14 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:21 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:01 PM
ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:05 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:50 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
4:02 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
4:02 PM
ANI Pharmaceuticals (Subject)
TANNENBAUM RENEE P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
3:59 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
6:47 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Fmr CIA Advisor reveals PEACEMAKER superweapon (Ad)

Kamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.

Full details are in this announcement.
05/13/2024
4:25 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:09 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
5:26 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:43 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/18/2024
3:50 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:33 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:19 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
6:59 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:41 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
8:33 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
5:28 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
8:12 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
8:13 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
8:53 PM
ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/05/2024
3:42 PM
ANI Pharmaceuticals (Filer)
Form ARS
04/02/2024
5:59 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:17 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:09 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
6:30 AM
ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
Form SC 13D/A
03/13/2024
3:44 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:48 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:07 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
5:58 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
5:39 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:43 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:25 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
8:42 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:21 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:11 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:16 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:58 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
4:31 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:24 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:18 PM
ANI Pharmaceuticals (Subject)
Pera Antonio R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:09 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:12 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:18 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:55 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:22 AM
ANI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
5:58 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:51 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:47 PM
ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:50 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:53 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:34 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:38 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:26 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The $15 "Insider Secret" That Could Save Your Retirement (Ad)

What if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.

Click here to discover the name and ticker of this "$15 billionaire-backed retirement stock" >>>
02/13/2024
7:05 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
5:06 AM
ANI Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
02/08/2024
7:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
5:14 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
4:32 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:52 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/19/2024
3:30 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
5:20 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
4:06 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ANIP) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners